Evaluating Hormone Therapy-associated Increases in Breast Density

作者: Gina R. Petroni , Jennifer A. Harvey , Viktor E. Bovbjerg , Mark E. Smolkin , Mark B. Williams

DOI: 10.1016/J.ACRA.2005.04.003

关键词:

摘要: Rationale and Objectives Changes in breast density, which are commonly associated with hormone replacement therapy (HRT) use, may imply changes cancer risk. This study explores the ability of different methods to detect (HRT)-associated increases density. Materials Methods Between 1997 2001, 51 postmenopausal women were reported have HRT-associated density at our institution. Twenty not an increase during same period selected as controls. Mammograms from date report earlier comparison used. Breast Imaging Reporting Data System (BI-RADS) categories both dates obtained mammography report. reviewed separate time points evaluated by assigning BI-RADS categories, visual assessment, computer-assisted quantitative analysis. Results Mammogram reports available for two patients. The remaining 49 HRT included. Reported resulted detection 57%, simultaneous assignment 61%, assessment 100%, 94% category change was only method that false-positive control Minimal most difficult detect, 90% these 21 cases detected 3 when defined least 5%. Conclusion Visual best identified including those minimal increases. Simultaneous considerably better than use categories. information be helpful guiding research design studies evaluating use.

参考文章(36)
Regine Sitruk-Ware, Hormonal replacement therapy. Reviews in Endocrine & Metabolic Disorders. ,vol. 3, pp. 243- 256 ,(2002) , 10.1023/A:1020028510797
Writing Group for the Women's Health Initiative Investigators, Writing Group for the Women's Health Initiative Investigators, None, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial JAMA. ,vol. 288, pp. 321- 333 ,(2002) , 10.1001/JAMA.288.3.321
Ingemar Persson, Elisabete Weiderpass, Leif Bergkvist, Reinhold Bergström, Catherine Schairer, Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes & Control. ,vol. 10, pp. 253- 260 ,(1999) , 10.1023/A:1008909128110
I Persson, E Thurfjell, L Holmberg, Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. Journal of Clinical Oncology. ,vol. 15, pp. 3201- 3207 ,(1997) , 10.1200/JCO.1997.15.10.3201
Wendie A. Berg, Cristina Campassi, Patricia Langenberg, Mary J. Sexton, Breast Imaging Reporting and Data System: inter- and intraobserver variability in feature analysis and final assessment. American Journal of Roentgenology. ,vol. 174, pp. 1769- 1777 ,(2000) , 10.2214/AJR.174.6.1741769
Carolyn M Rutter, Margaret T Mandelson, Mary B Laya, Stephen Taplin, Changes in Breast Density Associated With Initiation, Discontinuation, and Continuing Use of Hormone Replacement Therapy JAMA. ,vol. 285, pp. 171- 176 ,(2001) , 10.1001/JAMA.285.2.171
C H van Gils, J H C L Hendriks, R Holland, N Karssemeijer, J D M Otten, H Straatman, A L M Verbeek, Changes in mammographic breast density and concomitant changes in breast cancer risk. European Journal of Cancer Prevention. ,vol. 8, pp. 509- 515 ,(1999) , 10.1097/00008469-199912000-00006
N F Boyd, B O'Sullivan, J E Campbell, E Fishell, I Simor, G Cooke, T Germanson, Mammographic signs as risk factors for breast cancer British Journal of Cancer. ,vol. 45, pp. 185- 193 ,(1982) , 10.1038/BJC.1982.32
G. A. Greendale, B. A. Reboussin, S. Slone, C. Wasilauskas, M. C. Pike, G. Ursin, Postmenopausal Hormone Therapy and Change in Mammographic Density Journal of the National Cancer Institute. ,vol. 95, pp. 30- 37 ,(2003) , 10.1093/JNCI/95.1.30
J E Berkowitz, O M Gatewood, L E Goldblum, B W Gayler, Hormonal replacement therapy: mammographic manifestations. Radiology. ,vol. 174, pp. 199- 201 ,(1990) , 10.1148/RADIOLOGY.174.1.2152982